Related Experiment Video
Updated: May 31, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Serum concentrations in three children with unintentional tetrahydrozoline overdose
1Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri School of Medicine, Kansas City, MO 64108, USA. jlowry@cmh.edu
Insights
Tetrahydrozoline (THZ) eye drops can cause serious CNS and cardiovascular symptoms in children. This study reports three pediatric cases, calculating a THZ half-life of 4.4 hours in one instance.
Area of Science:
- Toxicology
- Pediatric Emergency Medicine
- Pharmacokinetics
Background:
- Tetrahydrozoline (THZ) ingestion in children can lead to severe central nervous system (CNS) depression and cardiovascular compromise.
- Over-the-counter (OTC) eye drops containing THZ pose a significant risk to young children if ingested.
- Limited human pharmacokinetic data exist for THZ following ingestion.
Observation:
- Three pediatric cases of THZ eye drop ingestion are presented.
- Symptoms included altered mental status, bradycardia, hypothermia, and hypotension.
- Two cases involved significant ingestion (7.5 mL), with one requiring intubation due to rapid deterioration.
Findings:
- Serum THZ concentrations were measured using gas-chromatography mass-spectrometry (GC-MS).
- A plasma half-life of 4.4 hours was calculated for THZ in one pediatric patient.
- All children recovered within 24 hours after intensive care observation.
Implications:
- This study provides valuable human pharmacokinetic data for tetrahydrozoline (THZ) in pediatric overdose cases.
- Understanding THZ toxicokinetics is crucial for managing pediatric ingestions and improving clinical outcomes.
- Highlights the importance of secure storage of OTC medications to prevent accidental pediatric ingestion.
Background:
Major symptoms can occur from tetrahydrozoline (THZ) overdoses in young children, requiring intensive care management. We report three cases that presented with CNS depression and cardiovascular effects where serum concentrations were performed.
Case Report:
Case 1 ingested an unknown amount of eye drops containing THZ, resulting in altered mental status, bradycardia, hypothermia, and hypotension. Cases 2 and 3 ingested 7.5 mL of eye drops containing THZ. Case 2 presented to the emergency department (ED) without symptoms but became lethargic and bradycardic 90 min after ingestion. By contrast, Case 3 became lethargic 15 min after ingestion and required intubation on arrival to the ED. All children were admitted to ICU for observation and improved within 24 h of ingestion. Urine obtained for drug screening was positive for THZ. Blood was obtained to assess level using gas-chromatography mass-spectrometry (GC-MS).
Case Discussion:
Case 1 had plasma levels of 51.4 and 23.6 ng/mL at 7 and 12 h, respectively, after ingestion, revealing a half-life of 4.4 h. Numerous case reports have been published documenting the dangers of ingesting these topical over-the-counter (OTC) products. However, human PK data are not available to help in our understanding of THZ toxicokinetics and disposition in humans after ingestion.
Conclusion:
We report three pediatric cases after ingestion of THZ where plasma concentrations were obtained with a calculated half-life of 4.4 h in one case.
Related Concept Videos
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Prevention of Further Absorption of Poison
Drug Toxicity: Dose-Dependent Reactions

